RIPK3 and neoplasm: The downregulation of RIPK3 (receptor-interacting protein kinase 3) in tumor-infiltrating MDSCs potentiated COX-2-mediated PGE2 production which further reduced RIPK3 and promoted the immunosuppressive activity of MDSCs.250